Leukemia study finds mutation that limits blood stem cells

06/5/2013 | Genetic Engineering & Biotechnology News

Researchers have discovered that a single mutation in the leukemia-associated gene JAK2 can reduce the ability of blood stem cells to replicate. The mutation is commonly present in patients with myeloproliferative neoplasms. The team plans to further study the effect of additional mutations on cells, which could provide clues on how leukemia develops. The findings were reported in PLOS Biology.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA